Industry Asks FDA To Relay Study Design Concerns Separately From IDE Decisions
This article was originally published in The Gray Sheet
Executive Summary
In comments on FDA’s draft investigational device exemption guidance, device manufacturers ask the agency to communicate any study design considerations or future considerations for IDE studies in communications separate from the official IDE decision letter.